Thoracoabdominal Wall Motion-Guided Biofeedback Treatment Of Abdominal Distension: A Randomized Placebo-Controlled Trial

Elizabeth Barba,Dan M. Livovsky,Anna Accarino,Fernando Azpiroz
DOI: https://doi.org/10.1053/j.gastro.2024.03.005
IF: 29.4
2024-03-13
Gastroenterology
Abstract:Background and Aims Abdominal distention results from abdominophrenic dyssynergia (diaphragmatic contraction and abdominal wall relaxation) in patients with disorders of the gut-brain interaction. This study aimed to validate a simple biofeedback procedure, guided by abdominothoracic wall motion, for treating abdominal distension. Methods In this randomized, parallel, placebo-controlled trial, 42 consecutive patients (36 women and 6 men; age, 17–64 years) with meal-triggered visible abdominal distension were recruited. Recordings of abdominal and thoracic wall motion were obtained using inductance plethysmography via adaptable belts. The signal was shown to patients in the biofeedback group, who were taught to mobilize the diaphragm. In contrast, the signal was not shown to the patients in the placebo group, who were given a placebo capsule. Three sessions were performed over a 4-week intervention period, with instructions to perform exercises (biofeedback group) or to take placebo three times a day (control group) at home. Outcomes were assessed through a) response to an offending meal (changes in abdominothoracic electromyographic activity and girth), and b) clinical symptoms measured using daily scales for 7 days. Results Patients in the biofeedback group (n=19) a) learned to correct abdominophrenic dyssynergia triggered by the offending meal (intercostal activity decreased by 82±10%, anterior wall activity increased by 97±6%, and the increase in girth was 108±4% smaller) and b) experienced improved clinical symptoms (abdominal distension scores decreased by 66±5%). These effects were not observed in the placebo group (all p<0.002). Conclusion Abdominothoracic wall movements serve as an effective biofeedback signal for correcting abdominophrenic dyssynergia and abdominal distention in patients with disorders of the gut-brain interaction. ClincialTrials.gov number, NCT04043208.
gastroenterology & hepatology
What problem does this paper attempt to address?